Refsav 200 Tablet

Refsav 200 Tablet is a prescription medicine that contains sacubitril and valsartan in each tablet. It belongs to the angiotensin receptor-neprilysin inhibitor (ARNI) class and is used to help treat chronic heart failure and lower the risk of hospitalisation in appropriate patients. Because this is Refsav 200 Tablet, it is a higher-strength tablet option in the Refsav range and is used only when a doctor has decided a stronger dose is needed.

How it works: In this tablet, sacubitril helps the body increase protective natural substances that relax blood vessels and reduce strain on the heart. Valsartan blocks angiotensin II, which helps blood vessels stay relaxed and lowers the heart’s workload, making Refsav 200 Tablet useful for selected heart failure patients.

Refsav 200 Tablet is the as-labelled 200 mg strength, which is stronger than Refsav 100 Tablet and Refsav 50 Tablet. Doctors may choose Refsav 200 Tablet for patients who have already been titrated up from lower strengths and can tolerate the effect on blood pressure, kidney function, and potassium levels. Compared with lower strengths, this tablet is more likely to cause a noticeable blood-pressure drop if the dose is too high for the individual.

• Chronic heart failure
• Reduced risk of heart-failure hospitalization
• Improving symptoms in selected patients with heart failure
• Blood pressure lowering when prescribed for a related condition

• Swallow Refsav 200 Tablet whole with water; do not crush, split, or chew unless your doctor or pharmacist specifically says it is allowed.
• Take it exactly at the schedule your doctor gives you, because the 200 mg strength is usually part of a planned dose increase rather than a starting dose.
• You may take it with or without food unless your prescriber gives different instructions.
• Try to take each dose at the same time every day to keep a steady level in your body.
• If this medicine makes you dizzy, rise slowly from sitting or lying positions and avoid driving until you know how it affects you.

Each Refsav 200 Tablet provides sacubitril 200 mg plus valsartan 200 mg, as labelled. It is typically taken twice daily in heart failure treatment, but the exact schedule and whether this strength is right for you must be decided by your doctor; the usual maximum is 1 tablet twice daily unless your prescriber directs otherwise. Refsav 200 Tablet is not meant to be a starting dose for most people and is generally used after lower strengths have been tolerated.

Do not change your dose or stop the medicine without speaking to your doctor.

Common side effects of Sacubitril + Valsartan may include:

• Dizziness, especially when standing up
• Low blood pressure
• Tiredness or weakness
• Cough
• Nausea
• Headache
• Raised potassium levels

• Do not use Refsav 200 Tablet during pregnancy; it can harm an unborn baby.
• Because this is a higher-strength tablet, it can cause more pronounced low blood pressure in sensitive patients.
• Avoid taking it together with an ACE inhibitor unless your doctor has instructed a safe washout period.
• Tell your doctor if you have kidney disease, liver disease, dehydration, or a history of angioedema.
• Be careful with alcohol, because it can increase dizziness and lightheadedness.
• Use caution when driving, operating machinery, or standing quickly until you know how the 200 mg strength affects you.
• Do not use potassium supplements or salt substitutes containing potassium unless your doctor approves them.

• ACE inhibitors such as enalapril or lisinopril
• Other blood pressure medicines, including diuretics, which may add to low blood pressure
• Potassium supplements or potassium-sparing diuretics such as spironolactone
• NSAIDs such as ibuprofen or naproxen, which can affect kidney function and reduce benefit
• Lithium, which can reach unsafe levels

Store Refsav 200 Tablet at room temperature in its original strip or box, away from excess moisture and heat.